Digital-supported Orofacial Myofunctional Therapy in OSA
ConditionObstructive Sleep Apnea (OSA)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHong Kong Metropolitan University
About this trial
This pilot study explores the feasibility, acceptability, and preliminary effectiveness of Digital-supported Orofacial Myofunctional Therapy (d-MFT), an innovative program combining facial recognition technology with evidence-based orofacial exercises for individuals with mild to moderate obstructive sleep apnoea (OSA). The d-MFT program aims to strengthen oropharyngeal muscles, improve airway function, and reduce OSA severity.
Participants receiving 3-month d-MFT (n=30) are expected to demonstrate greater improvements in OSA severity, sleep-related symptoms, and quality of life compared to those in the waitlist control group (n=30).
Feasibility and acceptability will be evaluated through outcome-based questionnaires and semi-structured interviews to explore participants' experiences, satisfaction, and perceived barriers to adherence.
Eligibility criteria
Qualifiers
Adults aged 18 years and above
Diagnosed with mild to moderate Obstructive Sleep Apnoea, defined as: Apnoea-Hypopnea Index of 5-30 events per hour
Indications for Continuous Positive Airway Pressure or oral appliance treatment, but unable to tolerate or decline these treatments
Body Mass Index less than 30 kg/m2
Disqualifiers
Presence of obstructive nasal disease or significant nasal obstruction
Unstable mental health issues
History of stroke
Unstable chronic respiratory, cardiac, neurological conditions
Trial design
Treatments tested in this trial
- Digital-supported Orofacial Myofunctional Therapy
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Hong Kong Metropolitan University
Lead sponsor
Queen Mary Hospital, Hong Kong
Collaborator
Source ClinicalTrials.gov